Home
IPO
Supriya Lifescience Ltd

Supriya Lifescience Ltd

Price Range (₹)

Rs. 265 to Rs. 274

Issue Size (₹ in Cr.)

Upto Rs. 700 cr

Minimum Quantity

54 shares

Bidding Period

Dec 16 – Dec 20, 2021

Open An Account

Strengths & Risks
30 second IPO
overview
Research Rating
Financials
Industry Trends
Key Strategies
Steps to Apply
Expert Review Video

About the Supriya Lifescience Ltd

One of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, they have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti allergic.

Were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume (Source: CRISIL Report as per Company DRHP).

Strengths

Significant scale with leadership position across key & niche products

The company believes their core strength lies in identifying generic molecules (off-patent) in the existing therapeutic segments which fits in to existing chemistry and production infrastructure and their ability to develop the product and scale-up production.

Backward integrated business model

As on May 2021, 11 of the existing products were backward integrated, which contributed 63.25% of the total revenue for nine months period ended December 31, 2020.

Geographically diversified revenues with a global presence across 78 countries

Customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda etc.

Risks

The business is subject to extensive regulation

Failure to comply with regulations prescribed by governments and regulatory agencies or to obtain, maintain or renew statutory and regulatory licenses, permits and approvals required to operate business, results of operations and financial condition could be adversely affected.

Manufacturing or quality control problems in such an industry may be detrimental

Such events may damage the company's reputation and expose them to litigation or other liabilities, which could adversely affect the results of operations and financial condition.

30 second IPO overview

15 Dec 2021 ICICI Securities

EXPERT REVIEW VIDEO

Expert Review Video

16 Dec 2021 ICICI Securities

ICICIdirect Research Rating

Avoid
Subscribe only for long term
Unrated
Subscribe

To read our Research Report Download Now

Financials

Net Worth
Revenue from Operations
Total Borrowings
Restated Profit for the Year
Restated Earnings per Share

Industry Trends

Global pharmaceutical market to grow at steady ~5.3% CAGR over the next five years

Global pharmaceutical market has grown by around 5.5-6.0% CAGR from ~USD 925 billion in CY14 to ~USD 1,300 billion in CY20. It is expected to sustain this growth over the next five years to reach USD 1,630-1,730 billion in CY25. (Source: Company DRHP).

Active pharmaceutical ingredients (APIs) form the major cost for formulation players

The raw material cost also includes the cost for inert materials i.e the materials used to stabilise the impact of APIs and preserve them for a longer period of time. However, the inert material cost does not form more than 10% of the overall raw materials.

Subscription Status

Retail Individual Investor
Non-Institutional Investor
Qualified Institutional Buyers
Overall

Why invest in IPO through ICICIdirect

Paperless

Applications

Hassle-free

refunds

Convenient investments

within a few clicks

Multiple modes

of application

Follow 3 simple steps TO APPLY IPO

Directly from Bank A/c
For ICICI Bank linked A/c
Using UPI
For non ICICI Bank A/c

Select IPO

Go to the IPO section, select the IPO you want to apply from the list and click on ‘Apply’.
Fill in the required details

Fill in the quantity of the number of shares you want to buy. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Confirm your request

Click on proceed to confirm the order. You can view the placed order under “order book”.

Select IPO

Choose the IPO you want to apply from the list. Click on Apply.
Fill in the required details

Fill in the quantity of shares. To apply at maximum price, check the cut-off price box and amount is auto calculated. If you want to apply at some other price within the price band, then you can enter the price manually by clicking on “Add bid” option.
Confirm your request

Check the A/C, UPI details and click on proceed. You will get an UPI link by which payment can be made.

Features & Benefits ICICIdirect

Trusted by

75 lakh+

customers

45+

Investments & Liability Products

One Click

Investment Basket

Access to

Award-winnin

Download Our App

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.